Unilever vows not to increase GSK bid Unilever has effectively ruled out a fourth takeover approach for GlaxoSmithKline’s consumer healthcare business after vowing not to increase its offer. Evening Standard · Jan 19, 2022
Little ingenuity needed to spot the weakness of THG The value of the e-commerce firm’s ‘end-to-end technology solutions’ doesn’t seem clear – no wonder investors went cold The Guardian - UK · Jan 18, 2022
Unilever ‘could lose credit rating’ with purchase of GSK consumer arm Deal could swell Unilever’s debt pile, says ratings agency Fitch The Guardian - UK · Jan 18, 2022
Unilever’s bid for GSK consumables isn’t quite the shocker it seems This could be a long campaign and, despite all the difficulties, there is a logic to the proposal The Guardian - UK · Jan 17, 2022
Unilever punished by City for failed £50bn tilt at GSK A PROPOSED fire-sale of under-performing food assets failed to stem the blood-letting at Unilever today as the City issued a damning verdict over its failed £50 billion tilt at GlaxoSmithKline. Evening Standard · Jan 17, 2022
Unilever to expand health and beauty business after failed GSK approach Dove soap maker’s shares are biggest faller on FTSE 100 after offer for consumer products arm is rebuffed The Guardian - UK · Jan 17, 2022
FTSE 100 Live: Unilever latest on Glaxo swoop, Credit Suisse boss quits, China GDP Shares in Marmite maker Unilever are sharply lower after it made an audacious swoop for GlaxoSmithKline's consumer healthcare arm. Evening Standard · Jan 17, 2022
India’s Modi calls for global approach to tackle crypto; FTSE 100 at two-year high – as it happened Rolling coverage of the latest economic and financial news The Guardian - UK · Jan 17, 2022
PPG Drops Its Bid for Akzo After Running Into a Dutch Wall Managers, unions, judges and politicians all said 'no' Fortune · Jun 1, 2017